[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,493
Citations 0
From the JAMA Network
March NaN, 2015

Surveillance of Adverse Psychiatric Medication Events

Author Affiliations
  • 1New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York
JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743

Psychiatric medications are among the most commonly prescribed drugs in the United States. In 2012, 472 million or 11.6% of all US dispensed prescriptions were for psychiatric medications.1 Many of these prescriptions were for clinical indications that have not been approved by the US Food and Drug Administration.2 Yet despite their widespread use, including for conditions for which there is limited evidence of clinical efficacy, little is known about the risks of adverse drug events associated with the major classes of psychiatric medications in community practice.

First Page Preview View Large
First page PDF preview
First page PDF preview